X0609 4 2026-09-04 0001815442 Kymera Therapeutics, Inc. KYMR 0001636994 Adams Brian false 500 NORTH BEACON STREET 4TH FLOOR WATERTOWN MA 02472 false true false false Chief Legal Officer false Common Stock 2026-09-04 4 S false 1209 115.55 D 55416 D Common Stock 2026-09-04 4 S false 3025 116.81 D 52391 D Common Stock 2026-09-04 4 S false 2137 117.57 D 50254 D Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not in the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.09 to $116.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.09 to $117.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.38 to $117.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Bruce Jacobs, as Attorney-in-Fact 2026-09-04